{"date":"2025-06-06","count":25,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6496-2025-06-06-1731-90lz2","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-06-06","time":"17:31:14","subject":"本公司註銷員工權利新股減資變更登記完成","clause":"第36款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-06-06 17:31，「本公司註銷員工權利新股減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2025-06-06-1704-4hfnnd","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2025-06-06","time":"17:04:56","subject":"公告本公司董事會委任第六屆薪資報酬委員會委員","clause":"第6款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2025-06-06 17:04，「公告本公司董事會委任第六屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2025-06-06-1704-2idaxb","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2025-06-06","time":"17:04:37","subject":"公告本公司董事會委任第二屆審計委員會委員","clause":"第6款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2025-06-06 17:04，「公告本公司董事會委任第二屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2025-06-06-1704-ii0q7i","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2025-06-06","time":"17:04:16","subject":"公告本公司113年現金股利配息基準日","clause":"第14款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2025-06-06 17:04，「公告本公司113年現金股利配息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-06-06-1659-p2ym0p","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-06-06","time":"16:59:20","subject":"公告本公司將受邀參加富邦證券之法說會訊息","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-06-06 16:59，「公告本公司將受邀參加富邦證券之法說會訊息」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-06-06-1606-1udd9xf","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-06-06","time":"16:06:19","subject":"公告本公司新任法人董事指派代表人","clause":"第6款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-06-06 16:06，「公告本公司新任法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6885-2025-06-06-1605-1hkj5dk","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2025-06-06","time":"16:05:56","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2025-06-06 16:05，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-06-06-1605-cw82fm","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-06-06","time":"16:05:48","subject":"公告本公司114年股東常會通過解除新任董事(含獨立董事)之競業禁止限制","clause":"第21款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-06-06 16:05，「公告本公司114年股東常會通過解除新任董事(含獨立董事)之競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-06-06-1605-7tp11o","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-06-06","time":"16:05:33","subject":"公告本公司薪資報酬委員會委員因董事全面改選致任期屆滿","clause":"第6款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-06-06 16:05，「公告本公司薪資報酬委員會委員因董事全面改選致任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-06-06-1605-13sk2v0","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-06-06","time":"16:05:17","subject":"公告本公司審計委員會委員異動","clause":"第6款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-06-06 16:05，「公告本公司審計委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2025-06-06-1605-1u8macb","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2025-06-06","time":"16:05:07","subject":"本公司撤回向美國食品藥物管理局提出的異體自然殺手細胞(Magicell-NK)第一/二期人體臨床試驗申請","clause":"第10款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2025-06-06 16:05，「本公司撤回向美國食品藥物管理局提出的異體自然殺手細胞(Magicell-NK)第一/二期人體臨床試驗申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-06-06-1605-1itkqku","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-06-06","time":"16:05:01","subject":"公告本公司114年股東常會全面改選董事(含獨立董事)當選名單及法人董事指派代表人","clause":"第6款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-06-06 16:05，「公告本公司114年股東常會全面改選董事(含獨立董事)當選名單及法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-06-06-1604-ds864w","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-06-06","time":"16:04:43","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-06-06 16:04，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-06-06-1550-2uwn42","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-06-06","time":"15:50:44","subject":"公告本公司股票即將終止興櫃交易並轉至證券交易所上巿交易","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-06-06 15:50，「公告本公司股票即將終止興櫃交易並轉至證券交易所上巿交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-06-06-1549-1ywsi7l","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-06-06","time":"15:49:43","subject":"公告本公司辦理股票初次上市前現金增資收足股款暨增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-06-06 15:49，「公告本公司辦理股票初次上市前現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-06-06-1547-icvqfo","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-06-06","time":"15:47:30","subject":"公告本公司辦理股票初次上市過額配售內容","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-06-06 15:47，「公告本公司辦理股票初次上市過額配售內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2025-06-06-1536-ggxbve","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2025-06-06","time":"15:36:54","subject":"公告本公司114年股東常會通過解除新任董事(含獨立董事)競業禁止之限制","clause":"第22款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2025-06-06 15:36，「公告本公司114年股東常會通過解除新任董事(含獨立董事)競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2025-06-06-1535-vkxfze","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2025-06-06","time":"15:35:50","subject":"公告本公司114年現金增資發行新股及認股基準日相關事宜","clause":"第9款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2025-06-06 15:35，「公告本公司114年現金增資發行新股及認股基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2025-06-06-1534-138pqlv","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2025-06-06","time":"15:34:39","subject":"公告本公司第三屆審計委員會成員異動","clause":"第6款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2025-06-06 15:34，「公告本公司第三屆審計委員會成員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-06-06-1506-1srfpx6","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-06-06","time":"15:06:35","subject":"本公司股東常會決議通過與杜康藥業股份有限公司合併案，依法向債權人公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-06-06 15:06，「本公司股東常會決議通過與杜康藥業股份有限公司合併案，依法向債權人公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2025-06-06-1506-1yybzie","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2025-06-06","time":"15:06:09","subject":"公告本公司114年股東常會補選董事(含獨立董事)當選名單","clause":"第6款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2025-06-06 15:06，「公告本公司114年股東常會補選董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-06-06-1505-enxquw","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-06-06","time":"15:05:19","subject":"公告本公司114年股東常會決議解除法人董事代表人競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-06-06 15:05，「公告本公司114年股東常會決議解除法人董事代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-06-06-1504-ds864w","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-06-06","time":"15:04:19","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-06-06 15:04，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2025-06-06-1500-ds864w","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2025-06-06","time":"15:00:12","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-06-06","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2025-06-06 15:00，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-06-06-1430-pxmcg1","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-06-06","time":"14:30:07","subject":"台灣浩鼎與美國TegMine Therapeutics合作，使用本公司GlycOBI醣鍵結技術平台開發ADC新藥","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-06-06 14:30，「台灣浩鼎與美國TegMine Therapeutics合作，使用本公司GlycOBI醣鍵結技術平台開發ADC新藥」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}